4

Changes in Ownership

Adaptive Biotechnologies Corp Filed 2020-03-11 Acc 0001209191-20-018103

Chief Financial Officer sold 15,000 shares at an average $24.58 ($368,679)

Chief Financial Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Documents 1

4 Changes in Ownership , xslF345X03/doc4.xml

Around this filing

2020-03-23 4 CEO and Chairman sold 16,680 shares at an average $22.50 ($375,236)
2020-03-11 4 Chief Financial Officer sold 15,000 shares at an average $24.58 ($368,679)
2020-02-24 4 President sold 85,000 shares at an average $33.57 ($2,853,294)

Link to a passage

External

SEC EDGAR (opens in new tab)

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Cohen Chad M Chief Financial Officer	2020-03-09	Option exercise	+12,300	$4.07	$50,061	13,300	D
Cohen Chad M Chief Financial Officer	2020-03-09	Sale	−9,321	$24.15	$225,102	3,979	D
Cohen Chad M Chief Financial Officer	2020-03-09	Sale	−2,979	$25.03	$74,564	1,000	D
Cohen Chad M Chief Financial Officer	2020-03-10	Option exercise	+2,700	$4.07	$10,989	3,700	D
Cohen Chad M Chief Financial Officer	2020-03-10	Sale	−2,700	$25.56	$69,012	1,000	D
Derivatives
Cohen Chad M Chief Financial Officer	2020-03-09	Option exercise · Stock Option (Right to Buy)	−12,300			47,700	D
Cohen Chad M Chief Financial Officer	2020-03-10	Option exercise · Stock Option (Right to Buy)	−2,700			45,000	D
Open-market sales · 15,000 sh · avg $24.58 · $368,679